Question · Q3 2025
Mark Schappel asked for additional color and details on how Paige AI complements and provides synergies to Tempus AI's genomic diagnostics business, specifically how digital pathology enhances sequencing.
Answer
Eric Lefkofsky (CEO, Tempus AI) explained that Paige AI's digital pathology algorithms can enhance sequencing by providing results when NGS fails (QNS or insufficient material) or by quickly predicting common mutations (e.g., EGFR in NSCLC) for critical cases. He emphasized a multimodal approach to generate high-quality, data-driven insights rapidly, aiming to be equally proficient in molecular, digitized pathology, and imaging data.